Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study

Davide Bimbatti, Cecilia Nasso, Domiziana Aspden, Sebastiano Buti, Ludovica Antonj, Alessio Signori, Elena Verzoni, Cristian Lolli, Marilena Di Napoli, Martina Fanelli, Miriam De Lucia, Cristina Masini, Giandomenico Roviello, Daniela Arduini, Roberto Filippi, Alessia Mennitto, Mariella Sorarù, Giovanni Bozza, Luigi Formisano, Carlo Messina, Lucia Bonomi, Annalisa Guida, Emanuela Fantinel, Sarah Scagliarini, Maria Giuseppa Vitale, Silvia Chiellino, Brigida Anna Maiorano, Filippo Maria Deppieri, Paolo Andrea Zucali, Alessia Cavo, Claudia Caserta, Francesca La Russa, Vincenza Conteduca, Francesca Maines, Silvia Zai, Francesco Pierantoni, Massimiliano Icardi, Pasquale Rescigno, Fabrizio Di Costanzo, Giuseppe Luigi Banna, Sara Elena Rebuzzi

Open source

DOI: 10.1177/17588359261470598
Published: 2026-08
Container: Therapeutic Advances in Medical Oncology
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/17588359261470598,
  title = {Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study},
  author = {Davide Bimbatti and Cecilia Nasso and Domiziana Aspden and Sebastiano Buti and Ludovica Antonj and Alessio Signori and Elena Verzoni and Cristian Lolli and Marilena Di Napoli and Martina Fanelli and Miriam De Lucia and Cristina Masini and Giandomenico Roviello and Daniela Arduini and Roberto Filippi and Alessia Mennitto and Mariella Sorarù and Giovanni Bozza and Luigi Formisano and Carlo Messina and Lucia Bonomi and Annalisa Guida and Emanuela Fantinel and Sarah Scagliarini and Maria Giuseppa Vitale and Silvia Chiellino and Brigida Anna Maiorano and Filippo Maria Deppieri and Paolo Andrea Zucali and Alessia Cavo and Claudia Caserta and Francesca La Russa and Vincenza Conteduca and Francesca Maines and Silvia Zai and Francesco Pierantoni and Massimiliano Icardi and Pasquale Rescigno and Fabrizio Di Costanzo and Giuseppe Luigi Banna and Sara Elena Rebuzzi},
  year = {2026},
  journal = {Therapeutic Advances in Medical Oncology},
  doi = {10.1177/17588359261470598},
  url = {https://doi.org/10.1177/17588359261470598}
}

RIS

TY  - JOUR
TI  - Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study
AU  - Davide Bimbatti
AU  - Cecilia Nasso
AU  - Domiziana Aspden
AU  - Sebastiano Buti
AU  - Ludovica Antonj
AU  - Alessio Signori
AU  - Elena Verzoni
AU  - Cristian Lolli
AU  - Marilena Di Napoli
AU  - Martina Fanelli
AU  - Miriam De Lucia
AU  - Cristina Masini
AU  - Giandomenico Roviello
AU  - Daniela Arduini
AU  - Roberto Filippi
AU  - Alessia Mennitto
AU  - Mariella Sorarù
AU  - Giovanni Bozza
AU  - Luigi Formisano
AU  - Carlo Messina
AU  - Lucia Bonomi
AU  - Annalisa Guida
AU  - Emanuela Fantinel
AU  - Sarah Scagliarini
AU  - Maria Giuseppa Vitale
AU  - Silvia Chiellino
AU  - Brigida Anna Maiorano
AU  - Filippo Maria Deppieri
AU  - Paolo Andrea Zucali
AU  - Alessia Cavo
AU  - Claudia Caserta
AU  - Francesca La Russa
AU  - Vincenza Conteduca
AU  - Francesca Maines
AU  - Silvia Zai
AU  - Francesco Pierantoni
AU  - Massimiliano Icardi
AU  - Pasquale Rescigno
AU  - Fabrizio Di Costanzo
AU  - Giuseppe Luigi Banna
AU  - Sara Elena Rebuzzi
PY  - 2026
JO  - Therapeutic Advances in Medical Oncology
DO  - 10.1177/17588359261470598
UR  - https://doi.org/10.1177/17588359261470598
ER  -

APA

Bimbatti, D., Nasso, C., Aspden, D., Buti, S., Antonj, L., Signori, A., Verzoni, E., Lolli, C., Napoli, M. D., Fanelli, M., Lucia, M. D., Masini, C., Roviello, G., Arduini, D., Filippi, R., Mennitto, A., Sorarù, M., Bozza, G., Formisano, L., Messina, C., Bonomi, L., Guida, A., Fantinel, E., Scagliarini, S., Vitale, M. G., Chiellino, S., Maiorano, B. A., Deppieri, F. M., Zucali, P. A., Cavo, A., Caserta, C., Russa, F. L., Conteduca, V., Maines, F., Zai, S., Pierantoni, F., Icardi, M., Rescigno, P., Costanzo, F. D., Banna, G. L., & Rebuzzi, S. E. (2026). Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/17588359261470598

Source records

crossref · retrieved 2026-09-26T06:08:12.730Z